Arai, Alshera M.
HRN: 24-48-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/17/2024
10/24/2024
IV
350 Mg
Q 6 Hours
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes